Breaking News

EUROAPI to Support Supply of Essential Meds to France and Europe

Invests in R&D activities at Vertolaye site to increase production of morphine that could increase productivity between 20% and 30%.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

EUROAPI has undertaken several initiatives to increase its production capacities for several active pharmaceutical ingredients (APIs) listed as essential medicines by the French authorities.   EUROAPI’s Francopia subsidiary dedicated to controlled substances, will invest in R&D activities at its Vertolaye (Puy-de-Dôme) site to increase EUROAPI’s production of morphine and its derivatives, as well as their antagonists used as antidotes, by 2027.   At the plant extraction stage, the Group ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters